| For: | Song YJ, Yang B, Feng QS, Ma FF, Xing B, Bin XL, Ha XQ. Gut microbiota-derived trimethylamine N-oxide exacerbates diabetic nephropathy by promoting renal fibrosis. World J Nephrol 2025; 14(4): 112066 [PMID: 41479812 DOI: 10.5527/wjn.v14.i4.112066] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v14/i4/112066.htm |
| Number | Citing Articles |
| 1 |
Venkata Subrahmanya Kumar Samanthapudi, Keila Carolina Ostos Mendoza, Sahithi Puvvala, Srinivasulu Kamma, Sivareddy Kotla. Trimethylamine-N-oxide (TMAO) in multiorgan disease: mechanisms, translational insights, and therapeutic opportunities. Drug Discovery Today 2026; : 104703 doi: 10.1016/j.drudis.2026.104703
|
| 2 |
You Wang, Lijia Wu, Xincui Bao, Jing Yang, Miao Xu, Yuzhuo Chang, Zhe Liu, Lingling Qin, Ming Gao, Cuiyan Lv, Tonghua Liu. Lipid metabolic dysregulation in diabetic kidney disease: mechanisms, cellular impact, and therapeutic strategies. Journal of Clinical & Translational Endocrinology 2026; 44: 100436 doi: 10.1016/j.jcte.2026.100436
|